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Supplementary Data 1
Detailed Analytical Parameters
1 Cut-oﬀ and internal standards concentrations
Table 1: Analyte and internal standards concentrations
Analyte Cut-oﬀ Internal Standard [IS]
(ng/mL) (ng/mL)
α-Hydroxyalprazolam 20 Triazolam-D4 100
Aripiprazole 10 Trazodone-D6 50
3-Hydroxy Bromazepam 20 Bromazepam-D4 450
Buprenorphine 5 Oxycodone-D3 100
Hydroxybupropion 20 Ephedrine-D3 100
N-Desmethylcitalopram 20 Citalopram-D6 40
N-Desmethylclobazam 20 Flunitrazepam-D7 20
Cocaethylene 20 Cocaine-D3 50
Norcodeine 20 Codeine-D3 100
N-Desmethylcyclobenzaprine 20 Amitriptyline-D3 40
Dextrorphan 20 Oxycodone-D3 100
Nordiazepam 20 Diazepam-D5 100
N-Desmethyl diphenydramine 20 Diphenhydramine-D3 200
Duloxetine 20 Amitriptyline-D3 40
Norfentanyl 0.5 Fentanyl-D5 10
7-Aminoﬂunitrazepam 20 7-Aminoclonazepam-D4 100
N-Desmethylﬂunitrazepam 20 Desalkylﬂurazepam-D4 100
Norﬂuoxetine 20 Amphetamine-D8 100
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Table 1: Analyte and internal standards concentrations
Analyte Cut-oﬀ Internal Standard [IS]
(ng/mL) (ng/mL)
2-Hydroxyethylﬂurazepam 20 Lorazepam-D4 300
Norketamine 20 Ketamine-D4 120
Lorazepam-glucuronide 40 Lorazepam-D4 300
mCPP 20 Amphetamine-D8 100
MDEA 20 MDMA-D5 7
MDPV metabolite 20 MDPV-D8 100
Normeperidine 40 Codeine-D3 100
α-Hydroxymidazolam 20 Diazepam-D5 100
N-desmethylmirtazapine 20 Amitriptyline-D3 40
6-Acetylmorphine 5 Codeine-D3 100
Morphine-6β-D-glucuronide 100 Morphine-D6 100
Naloxone 20 Oxymorphone-D3 100
Naltrexone 20 Oxycodone-D3 100
Desmethylolanzapine 20 Olanzapine-D8 20
Oxazepam-glucuronide 20 Oxazepam-D5 20
Phenylpropanolamine 30 Amphetamine-D8 100
Norpseudoephedrine 30 Amphetamine-D8 100
Norquetiapine 20 Quetiapine-D8 40
7-Hydroxyquetiapine 20 Quetiapine-D8 40
Temazepam-glucuronide 20 Diazepam-D5 100
α-Hydroxytriazolam 20 Triazolam-D4 100
N-Desmethylzopiclone 20 Zopiclone-D4 100
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2 Liquid chromatography method
Mobile phase A: methanol : 10 mM Ammonium formate pH 3.0 (2:98 v:v)
Mobile phase B: acetonitrile
Rinsing solution: methanol : 1% formic acid in water : isopropanol (50:25:25 v:v:v)
Analytical column: Zorbax Eclipse Plus C18, 2.1× 100 mm, 3.5 μm (Agilent)
2.1 LC pump gradient
Flow rate: 650 μL/min
Table 2: LC Pump Gradient












2.2 Autosampler and thermostat settings
• Injection volume: 5 μL
• Wash time: 10 sec
• Autosampler temperature: 4 ◦C
• Column oven temperature: 50 ◦C
3 Mass spectrometry method
3.1 Divert valve settings







3.2 Voltages and other conditions
• Scan type: scheduled multiple reaction monitoring (MRM)
• Polarity: positive
• MRM detection window: 45 sec
• Ion source: Turbo Spray
• Curtain Gas (CUR): 30.0
• Collision Gas (CAD): 10
• Ion Spray Voltage (IS): 3000.0 V
• Source temperature: 700.0 ◦C
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• Ion Source Gas 1 (GS1): 60.0
• Ion Source Gas (GS2): 65.0
Table 4: Monitored MRM transitions
Q1 Q3 Time Analyte DP EP CE CXP
(Da) (Da) (min) (V) (V) (V) (V)
281.2 117.0 8.3 Amitriptyline-D3 76 10 32 11
144.1 127.0 3.4 Amphetamine-D8 40 10 13 10
320.0 186.2 6.9 Bromazepam-D4 100 10 45 18
331.2 234.0 7.2 Citalopram-D6 85 10 40 15
290.1 254.0 4.8 7-Aminoclonazepam-D4 80 10 30 18
308.2 185.0 5.3 Cocaine-D3 30 10 21 15
303.3 215.0 3.5 Codeine-D3 110 10 36 18
290.1 89.0 9.8 Diazepam-D5 45 10 70 15
259.2 115.0 7.0 Diphenhydramine-D3 55 10 80 10
169.1 136.0 2.9 Ephedrine-D3 40 10 29 12
342.2 188.2 6.8 Fentanyl-D5 110 10 34 17
321.1 275.1 8.7 Flunitrazepam-D7 100 10 36 12
293.1 140.0 8.8 Desalkylﬂurazepam-D4 110 10 40 15
244.1 131.0 4.6 Ketamine-D4 64 10 43 12
327.1 281.0 8.3 Lorazepam-D4 70 10 33 15
199.1 165.1 4.0 MDMA-D5 60 10 20 15
285.2 175.1 5.3 MDPV-D8 75 10 31 15
292.1 152.1 1.7 Morphine-D6 100 10 79 14
321.1 261.1 4.0 Olanzapine-D8 40 10 26 25
292.1 246.1 8.1 Oxazepam-D5 60 10 30 14
319.2 259.0 3.8 Oxycodone-D3 95 10 35 15
305.2 287.0 1.9 Oxymorphone-D3 90 10 22 16
392.2 254.0 7.0 Quetiapine-D8 70 10 55 15
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Table 4: Monitored MRM transitions
Q1 Q3 Time Analyte DP EP CE CXP
(Da) (Da) (min) (V) (V) (V) (V)
379.2 182.1 6.2 Trazodone-D6 90 10 35 14
347.1 208.0 8.7 Triazolam-D4 100 10 70 18
393.1 245.0 4.9 Zopiclone-D4 60 10 26 10
325.1 297.2 8.0 α-Hydroxyalprazolam 1 110 10 38 11
325.1 216.1 8.0 α-Hydroxyalprazolam 2 110 10 56 18
448.1 285.1 8.3 Aripiprazole 1 80 10 37 10
448.1 176.1 8.3 Aripiprazole 2 80 10 42 11
332 287.0 6.0 3-Hydroxy Bromazepam 1 60 10 30 15
332.0 303.1 6.0 3-Hydroxy Bromazepam 2 60 10 30 15
468.3 396.2 7.6 Buprenorphine 1 20 10 55 10
468.3 414.3 7.6 Buprenorphine 2 20 10 50 10
256.1 130.1 5.0 Hydroxybupropion 1 50 10 48 12
256.1 103.1 5.0 Hydroxybupropion 2 50 10 49 18
312.2 110.1 7.1 N-Desmethylcitalopram 1 70 10 30 15
312.2 263.1 7.1 N-Desmethylcitalopram 2 70 10 24 25
287.1 245.0 8.3 N-Desmethylclobazam 1 100 10 28 15
287.1 210.0 8.3 N-Desmethylclobazam 2 100 10 42 13
319.2 197.1 6.1 Cocaethylene 1 100 10 20 15
318.2 150.0 6.1 Cocaethylene 2 100 10 28 15
286.1 115.0 3.3 Norcodeine 1 100 10 90 15
286.1 128.0 3.3 Norcodeine 2 100 10 80 15
263.2 216.0 8.0 N-Desmethylcyclobenzaprine 1 60 10 51 17
263.2 232.0 8.0 N-Desmethylcyclobenzaprine 2 60 10 22 21
259.2 158.1 4.8 Dextrorphan 1 85 10 53 17
258.2 115.0 4.8 Dextrorphan 2 85 10 83 15
271.1 140.0 8.9 Nordiazepam 1 95 10 42 13
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Table 4: Monitored MRM transitions
Q1 Q3 Time Analyte DP EP CE CXP
(Da) (Da) (min) (V) (V) (V) (V)
271.1 165.1 8.9 Nordiazepam 2 95 10 39 15
243.1 168.1 6.9 N-Desmethyl diphenydramine 1 40 10 20 15
243.1 153.1 6.9 N-Desmethyl diphenydramine 2 40 10 50 15
298.1 154.0 8.2 Duloxetine 1 60 10 9 9
298.1 44.0 8.2 Duloxetine 2 60 10 50 10
233.2 84.1 4.6 Norfentanyl 1 60 10 26 10
233.2 150.1 4.6 Norfentanyl 2 60 10 25 13
284.1 240.0 5.5 7-Aminoﬂunitrazepam 1 120 10 51 20
284.1 226.1 5.5 7-Aminoﬂunitrazepam 2 120 10 40 20
300.1 254.0 7.9 N-Desmethylﬂunitrazepam 1 85 10 36 15
300.1 198.1 7.9 N-Desmethylﬂunitrazepam 2 85 10 55 15
296.1 134.2 8.5 Norﬂuoxetine 1 65 10 10 10
296.1 296.1 8.5 Norﬂuoxetine 2 65 10 5 10
333.1 211.1 8.5 2-Hydroxyethylﬂurazepam 1 120 10 51 15
333.1 109.1 8.5 2-Hydroxyethylﬂurazepam 2 120 10 40 14
224.1 179.3 4.5 Norketamine 1 70 10 20 15
225.1 126.0 4.5 Norketamine 2 70 10 35 20
497.1 321.0 7.0 Lorazepam-glucuronide 1 70 10 20 24
497.1 275.1 7.0 Lorazepam-glucuronide 2 70 10 57 16
197.1 154.1 4.9 mCPP 1 75 10 20 13
197.1 118.0 4.9 mCPP 2 75 10 29 14
209.1 164.0 4.4 MDEA 1 60 10 14 15
209.1 136.1 4.4 MDEA 2 60 10 30 15
279.2 176.1 4.6 MDPV metabolite 1 50 10 23 20
279.2 127.2 4.6 MDPV metabolite 2 50 10 23 15
235.1 161.1 5.5 Normeperidine 1 60 10 22 15
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Table 4: Monitored MRM transitions
Q1 Q3 Time Analyte DP EP CE CXP
(Da) (Da) (min) (V) (V) (V) (V)
234.1 115.1 5.5 Normeperidine 2 60 10 85 11
253.2 196.2 5.0 N-desmethylmirtazapine 1 70 10 31 15
252.2 209.2 5.0 N-desmethylmirtazapine 2 70 10 22 20
342.1 168.1 7.3 α-Hydroxymidazolam 1 110 10 55 15
342.1 140.0 7.3 α-Hydroxymidazolam 2 110 10 84 12
328.2 165.0 4.0 6-Acetylmorphine 1 80 10 55 10
328.2 211.0 4.0 6-Acetylmorphine 2 80 10 37 10
462.1 286.1 1.6 Morphine-6β-D-glucuronide 1 50 10 44 14
462.1 165.0 1.6 Morphine-6β-D-glucuronide 2 50 10 71 15
328.2 212.2 3.4 Naloxone 1 100 10 55 15
328.2 253.2 3.4 Naloxone 2 100 10 38 15
342.2 270.1 3.9 Naltrexone 1 100 10 38 15
342.2 212.0 3.9 Naltrexone 2 100 10 60 20
299.1 213.1 3.9 Desmethylolanzapine 1 140 10 30 11
299.1 198.1 3.9 Desmethylolanzapine 2 140 10 42 12
463.1 241.1 6.5 Oxazepam-glucuronide 1 80 10 55 20
463.1 287.1 6.5 Oxazepam-glucuronide 2 80 10 25 20
152.1 117.1 2.3 Phenylpropanolamine 1 40 10 23 12
152.1 91.0 2.3 Phenylpropanolamine 2 40 10 47 16
152.1 134.1 2.5 Norpseudoephedrine 1 35 10 14 10
152.1 117.0 2.5 Norpseudoephedrine 2 35 10 23 10
297.1 140.1 6.9 Norquetiapine 1 70 10 80 15
297.1 184.0 6.9 Norquetiapine 2 70 10 53 15
401.1 270.0 4.7 7-Hydroxyquetiapine 1 30 10 35 18
401.1 209.1 4.7 7-Hydroxyquetiapine 2 30 10 60 20
477.1 301.1 7.2 Temazepam-glucuronide 1 85 10 21 9
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Table 4: Monitored MRM transitions
Q1 Q3 Time Analyte DP EP CE CXP
(Da) (Da) (min) (V) (V) (V) (V)
477.1 255.1 7.2 Temazepam-glucuronide 2 85 10 60 9
359 331.0 8.0 α-Hydroxytriazolam 1 100 10 40 10
359.0 176.0 8.0 α-Hydroxytriazolam 2 100 10 38 16
375.1 245.1 4.9 N-Desmethylzopiclone 1 70 10 25 10
375.1 217.0 4.9 N-Desmethylzopiclone 2 70 10 50 10
The method is validated on the following systems: HPLC Agilent 1200 series and 1260 Inﬁnity,
LC-MS/MS 5500 QTRAP Sciex.
The data acquisition software used is Analyst R© 1.6.2 build 8489 and the data analysis software
used is Multiquant R© 3.0.1 (Version 3.0.6256.0)
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